Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion type Assertion NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_head.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion description "[The TNFsRp55 level in heparinized plasma was 17% lower in patients with IDDM than in control subjects (3.93 +/- 0.22 vs. 4.72 +/- 0.24 micrograms/l, respectively, P = 0.038).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_provenance.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion evidence source_evidence_literature NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_provenance.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion SIO_000772 7926295 NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_provenance.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion wasDerivedFrom befree-20150227 NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_provenance.
- NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_assertion wasGeneratedBy ECO_0000203 NP410634.RACwqhG6kRlJyIXs-CqvsmYv2yv2sFcEhcxoQLsSODcTw130_provenance.